About Hangzhou Normal University
Hangzhou Normal University; traditional Chinese: 杭州師範大學; pinyin: Hángzhōu Shīfàn Dàxué, or Hangzhou Teachers College, is a public university in Hangzhou, the capital of Zhejiang Province, China.
Clinical Trials at Hangzhou Normal University
During the past decade, Hangzhou Normal University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hangzhou Normal University
According to Clinical.Site data, the most researched conditions in "Hangzhou Normal University" are
"Parkinson Disease" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Hangzhou Normal University" in a lesser frequency.
Clinical Trials Intervention Types at Hangzhou Normal University
Most popular intervention types in "Hangzhou Normal University" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "rTMS" (2 trials) and "Physical therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hangzhou Normal University
The vast majority of trials in "Hangzhou Normal University" are
2 trials for "All" genders.
Clinical Trials Status at Hangzhou Normal University
Currently, there are NaN active trials in "Hangzhou Normal University".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hangzhou Normal University,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hangzhou Normal University, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".